IDEXX Laboratories, Inc. (IDXX)Healthcare | Diagnostics & Research | Westbrook, United States | NasdaqGS
589.25 USD
+19.30
(3.386%)
⇧
(April 17, 2026, 4 p.m.
EDT)
After hours: 588.83 -0.42 (-0.423%) ⇩ (April 17, 2026, 5:48 p.m. EDT) Short-term: ★★☆☆☆ | Long-term: ★★★★☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 11, 2026, 2:59 p.m. EDT
IDXX is a high-risk stock with a strong beta and a relatively high price-to-book ratio, indicating it's expensive relative to its book value. The recent price history shows a mixed trend, with a recent dip to $563.0, which is near its 52-week low. While the stock has a positive earnings growth and revenue growth, the lack of dividends and the recent volatility suggest it's not ideal for dividend-focused investors. The options data indicates a cautious market sentiment, with both calls and puts showing significant activity, suggesting potential for a price move in either direction. Long-term investors might consider buying and holding if the fundamentals remain strong, but short-term traders should be cautious due to the high volatility and mixed signals from the options market. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.127113 |
| MSTL | 0.131021 |
| AutoETS | 0.133646 |
| AutoARIMA | 0.148554 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 48% |
| H-stat | 4.96 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.208 |
| Excess Kurtosis | -1.17 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 60.827 |
| Revenue per Share | 53.511 |
| Market Cap | 46,918,459,392 |
| Trailing P/E | 45.05 |
| Forward P/E | 35.92 |
| Beta | 1.72 |
| Profit Margins | 24.62% |
| Website | https://www.idexx.com |
As of April 11, 2026, 2:59 p.m. EDT: Options activity shows mixed signals. The calls and puts are showing significant volume and open interest in both out-of-the-money (OTM) and in-the-money (ITM) strikes, particularly around the ATM strike of 560. The IV spikes on both calls and puts suggest heightened volatility expectations. However, the overall trend in the options data seems to indicate a cautious outlook, with more activity in OTM strikes, which may suggest potential for either a significant price move or a consolidation phase. The presence of major OI walls on the higher strike calls indicates some speculative interest in a potential upward move, while the puts show a more defensive stance, especially with IV spikes on lower strikes. Overall, the options market appears to be cautious, with a balance between bullish and bearish sentiment.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.40157378 |
| Address1 | One IDEXX Drive |
| All Time High | 769.98 |
| All Time Low | 0.84375 |
| Ask | 590.39 |
| Ask Size | 1 |
| Audit Risk | 3 |
| Average Analyst Rating | 2.2 - Buy |
| Average Daily Volume10 Day | 494,910 |
| Average Daily Volume3 Month | 521,627 |
| Average Volume | 521,627 |
| Average Volume10Days | 494,910 |
| Beta | 1.722 |
| Bid | 588.12 |
| Bid Size | 1 |
| Board Risk | 1 |
| Book Value | 20.14 |
| City | Westbrook |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 5 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 589.25 |
| Current Ratio | 1.231 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 594.52 |
| Day Low | 580.4747 |
| Debt To Equity | 60.827 |
| Display Name | IDEXX Laboratories |
| Earnings Call Timestamp End | 1,777,984,200 |
| Earnings Call Timestamp Start | 1,777,984,200 |
| Earnings Growth | 0.179 |
| Earnings Quarterly Growth | 0.148 |
| Earnings Timestamp | 1,777,984,200 |
| Earnings Timestamp End | 1,777,984,200 |
| Earnings Timestamp Start | 1,777,984,200 |
| Ebitda | 1,505,213,952 |
| Ebitda Margins | 0.34974998 |
| Enterprise To Ebitda | 31.7 |
| Enterprise To Revenue | 11.087 |
| Enterprise Value | 47,714,902,016 |
| Eps Current Year | 14.51432 |
| Eps Forward | 16.40637 |
| Eps Trailing Twelve Months | 13.08 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fax | 207 556 4346 |
| Fifty Day Average | 604.1582 |
| Fifty Day Average Change | -14.908203 |
| Fifty Day Average Change Percent | -0.024675991 |
| Fifty Two Week Change Percent | 40.15738 |
| Fifty Two Week High | 769.98 |
| Fifty Two Week High Change | -180.72998 |
| Fifty Two Week High Change Percent | -0.23472036 |
| Fifty Two Week Low | 402.85 |
| Fifty Two Week Low Change | 186.4 |
| Fifty Two Week Low Change Percent | 0.46270323 |
| Fifty Two Week Range | 402.85 - 769.98 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 677,511,000,000 |
| Float Shares | 78,751,355 |
| Forward Eps | 16.40637 |
| Forward P E | 35.915928 |
| Free Cashflow | 790,735,872 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 11,000 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,775,001,600 |
| Gross Margins | 0.61797 |
| Gross Profits | 2,659,578,880 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.0070700003 |
| Held Percent Institutions | 0.95844 |
| Implied Shares Outstanding | 79,624,035 |
| Industry | Diagnostics & Research |
| Industry Disp | Diagnostics & Research |
| Industry Key | diagnostics-research |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,434,412,800 |
| Last Split Factor | 2:1 |
| Long Business Summary | IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. The company offers point-of-care diagnostic solutions, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology/morphology, and coagulation analyzers; and SNAP rapid assays test kits. It also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; UV Viewer Plus, a UV light cabinet which aids in the visual interpretation of fluorescent-based water tests; and veterinary software and services for independent veterinary clinics and corporate groups. In addition, the company offers diagnostic tests, services, and related instrumentation to manage the health status of livestock and poultry; human medical diagnostic products and services; and VetConnect PLUS, a cloud-based technology that enables veterinarians to access and analyze patients, as well as operates VetLab Station. It markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine. |
| Long Name | IDEXX Laboratories, Inc. |
| Market | us_market |
| Market Cap | 46,918,459,392 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_29729 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | 1,059,464,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 45,268,016,003 |
| Number Of Analyst Opinions | 14 |
| Open | 583.11 |
| Operating Cashflow | 1,181,805,056 |
| Operating Margins | 0.29764 |
| Overall Risk | 1 |
| Payout Ratio | 0.0 |
| Peg Ratio | 3.96 |
| Phone | 207 556 0300 |
| Post Market Change | -0.42321777 |
| Post Market Change Percent | -0.07182313 |
| Post Market Price | 588.8268 |
| Post Market Time | 1,776,462,489 |
| Previous Close | 569.95 |
| Price Eps Current Year | 40.597836 |
| Price Hint | 2 |
| Price To Book | 29.257696 |
| Price To Sales Trailing12 Months | 10.901884 |
| Profit Margins | 0.24618 |
| Quick Ratio | 0.76 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | buy |
| Recommendation Mean | 2.1875 |
| Region | US |
| Regular Market Change | 19.3 |
| Regular Market Change Percent | 3.38626 |
| Regular Market Day High | 594.52 |
| Regular Market Day Low | 580.4747 |
| Regular Market Day Range | 580.4747 - 594.52 |
| Regular Market Open | 583.11 |
| Regular Market Previous Close | 569.95 |
| Regular Market Price | 589.25 |
| Regular Market Time | 1,776,456,000 |
| Regular Market Volume | 493,244 |
| Return On Assets | 0.25586998 |
| Return On Equity | 0.66202 |
| Revenue Growth | 0.143 |
| Revenue Per Share | 53.511 |
| Sand P52 Week Change | 0.36506534 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 4 |
| Shares Outstanding | 79,424,539 |
| Shares Percent Shares Out | 0.024 |
| Shares Short | 1,908,770 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 1,747,294 |
| Short Name | IDEXX Laboratories, Inc. |
| Short Percent Of Float | 0.0274 |
| Short Ratio | 3.85 |
| Source Interval | 15 |
| State | ME |
| Symbol | IDXX |
| Target High Price | 823.0 |
| Target Low Price | 470.0 |
| Target Mean Price | 733.4286 |
| Target Median Price | 762.5 |
| Total Cash | 180,070,000 |
| Total Cash Per Share | 2.262 |
| Total Debt | 976,508,032 |
| Total Revenue | 4,303,702,016 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | 13.08 |
| Trailing P E | 45.049694 |
| Trailing Peg Ratio | 3.9647 |
| Triggerable | 1 |
| Two Hundred Day Average | 639.41296 |
| Two Hundred Day Average Change | -50.162964 |
| Two Hundred Day Average Change Percent | -0.07845159 |
| Type Disp | Equity |
| Volume | 493,244 |
| Website | https://www.idexx.com |
| Zip | 4,092 |